Dietary phytochemicals induce p53- and caspase-independent cell death in human neuroblastoma cells

International Journal of Developmental Neuroscience

Volumn 29, Issue 7, 2011, Pages 701-710

  Sukumari Ramesh, Sangeetha ^a   Bentley, J Nicole ^a   Laird, Melissa D ^a   Singh, Nagendra ^a   Vender, John R ^a   Dhandapani, Krishnan M ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Akt; Ayurveda; Chemotherapy; Nutrition; Pediatric cancer

Indexed keywords

ANDROGRAPHOLIDE; CASPASE 3; CISPLATIN; CURCUMIN; DIBENZOYLMETHANE DERIVATIVE; DOXORUBICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLANT MEDICINAL PRODUCT; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P53; SHORT HAIRPIN RNA; TANSHINONE IIA; WEDELOLACTONE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DIET; DRUG POTENTIATION; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NERVE CELL NECROSIS; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; BCL-X PROTEIN; CASPASES; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; CHALCONES; CHROMONES; COUMARINS; CURCUMIN; DIET; DITERPENES; DITERPENES, ABIETANE; HUMANS; MORPHOLINES; NEUROBLASTOMA; NF-KAPPA B; PLANT EXTRACTS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 80053570990     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2011.06.002     Document Type: Article

References (47)

1. Alonso M., Tamasdan C., Miller D.C., Newcomb E.W. Flavopiridol induces apoptosis in glioma cell lines independent of retinoblastoma and p53 tumor suppressor pathway alterations by a caspase-independent pathway. Mol. Cancer Ther. 2003, 2:139-150.
2. Balachandran P., Govindarajan R. Cancer-an ayurvedic perspective. Pharmacol. Res. 2005, 51:19-30.
3. Bian X., McAllister-Lucas L.M., Shao F., Schumacher K.R., Feng Z., Porter A.G., Castle V.P., Opipari A.W. NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells. J. Biol. Chem. 2001, 276:48921-48929.
4. Bian X., Opipari A.W., Ratanaproeksa A.B., Boitano A.E., Lucas P.C., Castle V.P. Constitutively active NFkappa B is required for the survival of S-type neuroblastoma. J. Biol. Chem. 2002, 277:42144-42150.
5. Biedler J.L., Helson L., Spengler B.A. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 1973, 33:2643-2652.
6. Biedler J.L., Spengler B.A., Chang T.D., Ross R.A. Transdifferentiation of human neuroblastoma cells results in coordinate loss of neuronal and malignant properties. Prog. Clin. Biol. Res. 1988, 271:265-276.
7. Cheng A.L., Hsu C.H., Lin J.K., Hsu M.M., Ho Y.F., Shen T.S., Ko J.Y., Lin J.T., Lin B.R., Ming-Shiang W., Yu H.S., Jee S.H., Chen G.S., Chen T.M., Chen C.A., Lai M.K., Pu Y.S., Pan M.H., Wang Y.J., Tsai C.C., Hsieh C.Y. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001, 21:2895-2900.
8. Cragg G.M., Newman D.J., Snader K.M. Natural products in drug discovery and development. J. Nat. Prod. 1997, 60:52-60.
9. Cui H., Schroering A., Ding H.F. p53 mediates DNA damaging drug-induced apoptosis through a caspase-9-dependent pathway in SH-SY5Y neuroblastoma cells. Mol. Cancer Ther. 2002, 1:679-686.
10. Dhandapani K.M., Mahesh V.B., Brann D.W. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors. J. Neurochem. 2007, 102:522-538.
11. Dole M., Nunez G., Merchant A.K., Maybaum J., Rode C.K., Bloch C.A., Castle V.P. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res. 1994, 54:3253-3259.
12. Dole M.G., Jasty R., Cooper M.J., Thompson C.B., Nunez G., Castle V.P. Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res. 1995, 55:2576-2582.
13. Eisenberg H.M., Gary H.E., Aldrich E.F., Saydjari C., Turner B., Foulkes M.A., Jane J.A., Marmarou A., Marshall L.F., Young H.F. Initial CT findings in 753 patients with severe head injury. A report from the NIH Traumatic Coma Data Bank. J. Neurosurg. 1990, 73:688-698.
14. Gabrielian E.S., Shukarian A.K., Goukasova G.I., Chandanian G.L., Panossian A.G., Wikman G., Wagner H. A double blind, placebo-controlled study of Andrographis paniculata fixed combination Kan Jang in the treatment of acute upper respiratory tract infections including sinusitis. Phytomedicine 2002, 9:589-597.
15. Holder G.M., Plummer J.L., Ryan A.J. The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat. Xenobiotica 1978, 8:761-768.
16. Humpl T. Neuroblastoma. World J. Urol. 1995, 13:233-239.
17. Karacay B., Sanlioglu S., Griffith T.S., Sandler A., Bonthius D.J. Inhibition of the NF-kappaB pathway enhances TRAIL-mediated apoptosis in neuroblastoma cells. Cancer Gene Ther. 2004, 11:681-690.
18. Karmakar S., Banik N.L., Patel S.J., Ray S.K. Curcumin activated both receptor-mediated and mitochondria-mediated proteolytic pathways for apoptosis in human glioblastoma T98G cells. Neurosci. Lett. 2006, 407:53-58.
19. Kelloff G.J., Crowell J.A., Steele V.E., Lubet R.A., Malone W.A., Boone C.W., Kopelovich L., Hawk E.T., Lieberman R., Lawrence J.A., Ali I., Viner J.L., Sigman C.C. Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J. Nutr. 2000, 130:467S-471S.
20. Kim N.H., Kim K., Park W.S., Son H.S., Bae Y. PKB/Akt inhibits ceramide-induced apoptosis in neuroblastoma cells by blocking apoptosis-inducing factor (AIF) translocation. J. Cell Biochem. 2007, 102:1160-1170.
21. King, M.D., McCracken, D.J., Wade, F.M., Meiler, S.E., Alleyne, C.H., Dhandapani, K.M., 2011. Attenuation of hematoma size and neurological injury with curcumin following intracerebral hemorrhage in mice. J. Neurosurg. [Epub ahead of print], PMID: 21417704.
22. Kobori M., Yang Z., Gong D., Heissmeyer V., Zhu H., Jung Y.K., Gakidis M.A., Rao A., Sekine T., Ikegami F., Yuan C., Yuan J. Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK complex. Cell Death Differ. 2004, 11:123-130.
23. Kulichenko L.L., Kireyeva L.V., Malyshkina E.N., Wikman G. A randomized, controlled study of Kan Jang versus amantadine in the treatment of influenza in Volgograd. J. Herb. Pharmacother. 2003, 3:77-93.
24. Laird M.D., Sukumari-Ramesh S., Swift A.E., Meiler S.E., Vender J.R., Dhandapani K.M. Curcumin attenuates cerebral edema following traumatic brain injury in mice: a possible role for aquaporin-4?. J. Neurochem. 2010, 113:637-648.
25. Lavoie S., Chen Y., Dalton T.P., Gysin R., Cuenod M., Steullet P., Do K.Q. Curcumin, quercetin, and tBHQ modulate glutathione levels in astrocytes and neurons: importance of the glutamate cysteine ligase modifier subunit. J. Neurochem. 2009, 108:1410-1422.
26. Liontas A., Yeger H. Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma. Anticancer Res. 2004, 24:987-998.
27. Meng F., Liu L., Chin P.C., D'Mello S.R. Akt is a downstream target of NF-kappa B. J. Biol. Chem. 2002, 277:29674-29680.
28. Mora J., Cheung N.K., Juan G., Illei P., Cheung I., Akram M., Chi S., Ladanyi M., Cordon-Cardo C., Gerald W.L. Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell. Cancer Res. 2001, 61:6892-6898.
29. Murakami Y., Ito S., Atsumi T., Fujisawa S. Theoretical prediction of the relationship between phenol function and COX-2/AP-1 inhibition for ferulic acid-related compounds. In Vivo 2005, 19:1039-1043.
30. Negi A.S., Kumar J.K., Luqman S., Shanker K., Gupta M.M., Khanuja S.P. Recent advances in plant hepatoprotectives: a chemical and biological profile of some important leads. Med. Res. Rev. 2008, 28:746-772.
31. Opel D., Poremba C., Simon T., Debatin K.M., Fulda S. Activation of Akt predicts poor outcome in neuroblastoma. Cancer Res. 2007, 67:735-745.
32. Ouyang W., Li J., Ma Q., Huang C. Essential roles of PI-3K/Akt/IKKbeta/NFkappaB pathway in cyclin D1 induction by arsenite in JB6 Cl41 cells. Carcinogenesis 2006, 27:864-873.
33. Panossian A., Hovhannisyan A., Mamikonyan G., Abrahamian H., Hambardzumyan E., Gabrielian E., Goukasova G., Wikman G., Wagner H. Pharmacokinetic and oral bioavailability of andrographolide from Andrographis paniculata fixed combination Kan Jang in rats and human. Phytomedicine 2000, 7:351-364.
34. Rajeevan M.S., Ranamukhaarachchi D.G., Vernon S.D., Unger E.R. Use of real-time quantitative PCR to validate the results of cDNA array and differential display PCR technologies. Methods 2001, 25:443-451.
35. Ronchetti D., Impagnatiello F., Guzzetta M., Gasparini L., Borgatti M., Gambari R., Ongini E. Modulation of iNOS expression by a nitric oxide-releasing derivative of the natural antioxidant ferulic acid in activated RAW 264.7 macrophages. Eur. J. Pharmacol. 2006, 532:162-169.
36. Ross R.A., Spengler B.A., Biedler J.L. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J. Natl. Cancer Inst. 1983, 71:741-747.
37. Scapagnini G., Colombrita C., Amadio M., D'Agata V., Arcelli E., Sapienza M., Quattrone A., Calabrese V. Curcumin activates defensive genes and protects neurons against oxidative stress. Antioxid. Redox Signal. 2006, 8:395-403.
38. Schmidt M.L., Lukens J.N., Seeger R.C., Brodeur G.M., Shimada H., Gerbing R.B., Stram D.O., Perez C., Haase G.M., Matthay K.K. Biologic factors determine prognosis in infants with stage IV neuroblastoma: a prospective Children's Cancer Group study. J. Clin. Oncol. 2000, 18:1260-1268.
39. Singletary K., MacDonald C., Iovinelli M., Fisher C., Wallig M. Effect of the beta-diketones diferuloylmethane (curcumin) and dibenzoylmethane on rat mammary DNA adducts and tumors induced by 7,12-dimethylbenz[a]anthracene. Carcinogenesis 1998, 19:1039-1043.
40. Stiller C.A., Parkin D.M. International variations in the incidence of neuroblastoma. Int. J. Cancer 1992, 52:538-543.
41. Sukumari-Ramesh S., Laird M.D., Singh N., Vender J.R., Alleyne C.H., Dhandapani K.M. Astrocyte-derived glutathione attenuates hemin-induced apoptosis in cerebral microvascular cells. Glia 2010, 58:1858-1870.
42. Thiyagarajan M., Sharma S.S. Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci. 2004, 74:969-985.
43. Venkatesan N. Curcumin attenuation of acute adriamycin myocardial toxicity in rats. Br. J. Pharmacol. 1998, 124:425-427.
44. Venkatesan N., Punithavathi D., Arumugam V. Curcumin prevents adriamycin nephrotoxicity in rats. Br. J. Pharmacol. 2000, 129:231-234.
45. Wakade C., King M.D., Laird M.D., Alleyne C.H., Dhandapani K.M. Curcumin attenuates vascular inflammation and cerebral vasospasm after subarachnoid hemorrhage in mice. Antioxid. Redox Signal. 2009, 11:35-45.
46. Wang Y.J., Pan M.H., Cheng A.L., Lin L.I., Ho Y.S., Hsieh C.Y., Lin J.K. Stability of curcumin in buffer solutions and characterization of its degradation products. J. Pharm. Biomed. Anal. 1997, 15:1867-1876.
47. Wu A., Ying Z., Gomez-Pinilla F. Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress, synaptic plasticity, and cognition. Exp. Neurol. 2006, 197:309-317.